Delivery Order SPE2DB20D3303-SPE2DB24FA1KE
Award Date
7/24/24
Potential Completion Date
8/14/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets. The contract has a ceiling value of $8,076.65 and an ultimate completion date of September 12, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, is leveraging its federal contracting experience and extensive supply chain to deliver this critical medication to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Envarsus XR 4 mg tablets, a specialty pharmaceutical product, with a ceiling value of $4,845.99 and a period of performance through May 1, 2024. The contract is structured as a firm fixed price delivery order and does not have a set-aside...
This is a delivery order award worth $6,461.32 to AmerisourceBergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA). The order is for the pharmaceutical product Envarsus XR 4 mg tablet, which is a critical medical supply. The contract has a completion date of September 27, 2024 and is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, particularly the Department of Defense and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of Envarsus XR 1 mg tablets. The $1,216.11 firm fixed-price contract has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities. This specific...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $3,230.68, is for the delivery of Envarsus XR 4 mg tablets, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 18, 2024. This award is not associated with any set-aside designation. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,148.10, is for the provision of Envarsus XR 1 mg tablets, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) type and has an ultimate completion date of April 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Envarsus XR 0.75 mg tablets over a period ending on October 9, 2024. The contract has a ceiling value of $1,103.64 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,432.22 firm fixed-price contract is for the supply of 4,565,699,109 units of the prescription drug Envarsus XR 1 mg tablets. The contract has an ultimate completion date of September 26, 2024 and is not set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Envarsus XR 4 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $1,615.33 and an ultimate completion date of August 26, 2024. The contract is not set aside for any specific socioeconomic program. As one of the largest pharmaceutical distributors in the U.S., Amerisourcebergen leverages its extensive supply chain...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,687.28 firm fixed-price contract is for the delivery of Envarsus XR 4 mg tablets, a transplant medication, to support military and federal healthcare programs. The contract has an ultimate completion date of August 21, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...